Retraction
Dapagliflozin Ameliorates STZ-Induced Cardiac Hypertrophy in Type 2 Diabetic Rats by Inhibiting the Calpain-1 Expression and Nuclear Transfer of NF-κB
Paper Information
Record ID:
59839
Author(s):
Publication Date:
January 20, 2022
Retraction Date:
December 06, 2023
(2.0 year years ago)
Subjects:
Specific Fields:
Biochemistry Biology - Cellular Toxicology Medicine - Cardiology Medicine - Diabetes
Biochemistry Biology - Cellular Toxicology Medicine - Cardiology Medicine - Diabetes
Institutions:
Country:
🇨🇳 ChinaArticle Type:
Publisher:
Hindawi
Open Access:
Yes
DOI:
PubMed ID:
Retraction PubMed ID:
Retraction Details
Citations (6)
6
Total Citations1
Post-Retraction(16.7%)
4
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
0
Within 30 days
1
Within 1 year
0
After 2+ years
96
Days since retraction (latest)
Heavy Metals Removal Using Carbon Based Nanocomposites
Unknown Authors
Unknown Journal
Published: Unknown
Role and molecular mechanisms of SGLT2 inhibitors in pathological cardiac remodeling (Review)
Bixian Chen, Jing Guo, Ye Hongmei et al. (5 authors)
Molecular Medicine Reports
Open Access
Published: Mar 2024
10 citations
10 citations
96 days after retraction
The effect of dapagliflozin on myocardial ischemia–reperfusion injury in diabetic rats
Shilong Xiong, Donghua Mo, Yingjun Wu et al. (6 authors)
Canadian Journal of Physiology and Pharmacology
Published: Jan 2023
4 citations
4 citations
331 days before retraction
Retracted: Dapagliflozin Ameliorates STZ‐Induced Cardiac Hypertrophy in Type 2 Diabetic Rats by Inhibiting the Calpain‐1 Expression and Nuclear Transfer of NF‐<i>κ</i>B
Computational and Mathematical Methods in Medicine
Computational and Mathematical Methods in Medicine
Open Access
Published: Jan 2023
339 days before retraction
An integrated RNA sequencing and network pharmacology approach reveals the molecular mechanism of dapagliflozin in the treatment of diabetic nephropathy
Zhenyu Bai, Ting Xie, Tianhao Liu et al. (10 authors)
Frontiers in Endocrinology
Open Access
Published: Sep 2022
5 citations
5 citations
441 days before retraction
Dapagliflozin Improves Diabetic Cardiomyopathy by Modulating the Akt/mTOR Signaling Pathway
Meng-xiang Ren, Da-Bin Pan, Dayong Zha et al. (4 authors)
BioMed Research International
Open Access
Published: Jul 2022
4 citations
4 citations
498 days before retraction
Quick Stats
Total Citations:
12
Years Since Retraction:
2.0 year
Open Access:
Yes
Last Checked:
Jul 24, 2025